0001239819-23-000049.txt : 20230317
0001239819-23-000049.hdr.sgml : 20230317
20230317172102
ACCESSION NUMBER: 0001239819-23-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230317
DATE AS OF CHANGE: 20230317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nestro Gene
CENTRAL INDEX KEY: 0001795637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52008
FILM NUMBER: 23743882
MAIL ADDRESS:
STREET 1: C/O LUNA INNOVATIONS, INC.
STREET 2: 301 1ST STREET, SW, SUITE 200
CITY: ROANOKE
STATE: VA
ZIP: 24011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LUNA INNOVATIONS INC
CENTRAL INDEX KEY: 0001239819
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 FIRST STREET SW
STREET 2: SUITE 200
CITY: ROANOKE
STATE: VA
ZIP: 24011
BUSINESS PHONE: 540-769-8400
MAIL ADDRESS:
STREET 1: 301 FIRST STREET SW
STREET 2: SUITE 200
CITY: ROANOKE
STATE: VA
ZIP: 24011
4
1
wf-form4_167908804971362.xml
FORM 4
X0306
4
2023-03-15
0
0001239819
LUNA INNOVATIONS INC
LUNA
0001795637
Nestro Gene
C/O LUNA INNOVATIONS INCORPORATED
301 1ST STREET, SW, SUITE 200
ROANOKE
VA
24011
0
1
0
0
Chief Financial Officer
Common Stock
2023-03-15
4
A
0
7147
0
A
192217
D
Common Stock
2023-03-15
4
F
0
2152
6.50
D
190065
D
Represents the satisfaction of the performance-based vesting condition with respect to a long-term, performance-based restricted stock unit award granted to the reporting person on January 8, 2020, based on the Issuer's 2022 financial results. The number of shares reported reflects the extent of such achievement. In light of the performance-based vesting conditions of the award, such award was not reportable under Section 16 until vesting was determined, which occurred on March 15, 2023.
These shares were repurchased by the Issuer pursuant to the election of the holder to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
/s/ Scott A. Graeff, Attorney-In-Fact
2023-03-17